Cargando…

Cardiovascular Effect of Epoprostenol and Intravenous Cardiac Drugs for Acute Heart Failure on Canine Pulmonary Hypertension

SIMPLE SUMMARY: Pulmonary hypertension is a life-threatening complication in dogs with cardiopulmonary disease. Epoprostenol, a prostacyclin analog, is an intravenous pulmonary vasodilator used for treating pulmonary hypertension in humans; however, it has not been used in veterinary medicine. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuchi, Yunosuke, Suzuki, Ryohei, Satomi, Shuji, Saito, Takahiro, Teshima, Takahiro, Matsumoto, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144573/ https://www.ncbi.nlm.nih.gov/pubmed/37104457 http://dx.doi.org/10.3390/vetsci10040302

Ejemplares similares

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Optimal Intravenous Administration Procedure for Efficient Delivery of Canine Adipose-Derived Mesenchymal Stem Cells
por: Yasumura, Yuyo, et al.
Publicado: (2022)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Comparative study of myocardial function in cases of feline hypertrophic cardiomyopathy with and without dynamic left-ventricular outflow-tract obstruction
por: Saito, Takahiro, et al.
Publicado: (2023)

Right Ventricular Myocardial Adaptation Assessed by Two-Dimensional Speckle Tracking Echocardiography in Canine Models of Chronic Pulmonary Hypertension
por: Yuchi, Yunosuke, et al.
Publicado: (2021)

Echocardiographic characteristics of dogs with pulmonary hypertension secondary to respiratory diseases
por: Yuchi, Yunosuke, et al.
Publicado: (2023)

Immunomodulatory Effects of Canine Adipose Tissue Mesenchymal Stem Cell-Derived Extracellular Vesicles on Stimulated CD4(+) T Cells Isolated from Peripheral Blood Mononuclear Cells
por: Teshima, Takahiro, et al.
Publicado: (2021)

Pulmonary Vascular Resistance Estimated by Echocardiography in Dogs With Myxomatous Mitral Valve Disease and Pulmonary Hypertension Probability
por: Suzuki, Ryohei, et al.
Publicado: (2021)

Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension
por: Yuchi, Yunosuke, et al.
Publicado: (2023)

Utility of tricuspid annular plane systolic excursion normalized by right ventricular size indices in dogs with postcapillary pulmonary hypertension
por: Yuchi, Yunosuke, et al.
Publicado: (2020)

Detection of Congestive Heart Failure and Myocardial Dysfunction in Cats With Cardiomyopathy by Using Two-Dimensional Speckle-Tracking Echocardiography
por: Suzuki, Ryohei, et al.
Publicado: (2021)

A Case of a Small-Breed Dog with Diet-Related Dilated Cardiomyopathy Showing Marked Improvements in Cardiac Morphology and Function after Dietary Modification
por: Saito, Takahiro, et al.
Publicado: (2022)

Early detection of myocardial dysfunction in a cat that gradually progressed to endomyocardial form of restrictive cardiomyopathy
por: Saito, Takahiro, et al.
Publicado: (2021)

Fecal microbiota transplantation as a new treatment for canine inflammatory bowel disease
por: NIINA, Ayaka, et al.
Publicado: (2020)

Influence of heart rate on right ventricular function assessed by right heart catheterization and echocardiography in healthy anesthetized dogs
por: Yuchi, Yunosuke, et al.
Publicado: (2022)

Utility of Real-Time Three-Dimensional Echocardiography for the Assessment of Right Ventricular Morphology and Function in Large Animal Models
por: Yuchi, Yunosuke, et al.
Publicado: (2022)

Right ventricular systolic and diastolic function assessed by two-dimensional speckle tracking echocardiography in dogs with myxomatous mitral valve disease
por: YUCHI, Yunosuke, et al.
Publicado: (2021)

Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol
por: Suzuki, Ryohei, et al.
Publicado: (2019)

Left and Right Myocardial Functionality Assessed by Two-Dimensional Speckle-Tracking Echocardiography in Cats with Restrictive Cardiomyopathy
por: Suzuki, Ryohei, et al.
Publicado: (2021)

Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease
por: Niina, Ayaka, et al.
Publicado: (2019)

Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan
por: Akiyama, Noriyoshi, et al.
Publicado: (2023)

Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
por: Timofeev, Julia, et al.
Publicado: (2013)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Generation of Insulin-Producing Cells from Canine Adipose Tissue-Derived Mesenchymal Stem Cells
por: Teshima, Takahiro, et al.
Publicado: (2020)

Immortalized Canine Adipose-Derived Mesenchymal Stem Cells as a Novel Candidate Cell Source for Mesenchymal Stem Cell Therapy
por: Yasumura, Yuyo, et al.
Publicado: (2023)

Left ventricular geometric characteristics predict response to carvedilol in cats with asymptomatic hypertrophic obstructive cardiomyopathy caused by systolic anterior motion of the mitral valve
por: MOCHIZUKI, Yohei, et al.
Publicado: (2019)

Antiviral Effects of Adipose Tissue-Derived Mesenchymal Stem Cells Secretome against Feline Calicivirus and Feline Herpesvirus Type 1
por: Teshima, Takahiro, et al.
Publicado: (2022)

Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension
por: Kimura, Mai, et al.
Publicado: (2015)

Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report
por: Alexandre, André, et al.
Publicado: (2023)

Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis
por: Teshima, Takahiro, et al.
Publicado: (2015)

Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion
por: Teshima, Takahiro, et al.
Publicado: (2018)

Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
por: Mohammadi, Asma, et al.
Publicado: (2021)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
por: Teshima, Takahiro, et al.
Publicado: (2016)

Reversible Cardiac Hypertrophy in Pulmonary Arterial Hypertension Treated With High-Dose Epoprostenol
por: Izumi, Keiichi, et al.
Publicado: (2022)

Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost—A Multicentre, Retrospective Study
por: Camara, Raquel Paulinetti, et al.
Publicado: (2023)

Epoprostenol: Flushing or Erythroderma?
por: Martínez-Martínez, María Luisa, et al.
Publicado: (2013)

A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension
por: Nishiura, Kazuto, et al.
Publicado: (2023)

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
por: Abughazaleh, Shaadi, et al.
Publicado: (2020)

Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience
por: Sitbon, Olivier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o4vki963g5g6i7tmqf8me3in0a